Professional background

Biography image

Roy L.Turnell

Partnermoc.eniHnospmohT@llenruT.yoR

O 216.566.5604

Roy L.Turnell

Partner

moc.eniHnospmohT@llenruT.yoR

O 216.566.5604

Focus Areas

Representing a publicly held U.S. sterility company in its acquisition of a much larger U.S.-based industry leader in sterilizer manufacturing.
Counseling a publicly held Irish medical product company in its acquisition of a U.S.-based sterile packaging company.
Advising a publicly held U.S. medical product company in its acquisition of a specialty health care company, including advice on the contractual relationship between the target and a Korean supplier.
Representing a publicly held U.S. chemical concern in its acquisition of a privately held chemical company.
Advising a UK-based company with a global presence in its acquisition of U.S.-based a halocarbon management and gas reclamation company.
Counseling the same UK-based company in its acquisition of assets of a U.S. supplier of refrigerant gases.
Representing an Ireland-based manufacturing company in its first U.S. acquisition.
Advising a UK-based company in its acquisition of a U.S. manufacturer of precision manufacturing control devices.
Counseling a publicly held U.S. sterility company in its acquisition of a UK manufacturer of chemical sterility indicators.
Representing a publicly held U.S. sterility company in its acquisition of a Swiss manufacturer of specialty washing machines.
Representing a publicly held U.S. sterility company in its acquisition of a Swedish producer of automated laboratory cleaning systems.
Counseling a publicly held Canadian steel distributor in multiple acquisitions of U.S. steel service centers and in dealings with concerns in Japan, Germany and Italy.
Advising a publicly held Greek mining concern in the U.S. portion of its acquisition of assets from a major German industrial materials firm.
Representing a publicly held Greek mining concern in negotiations for U.S. mining properties.
Counseling a Belgium-based pharmaceutical company in comprehensive cross-border negotiations with a major U.S. based pharmaceutical company for co-development and co-promotion of a potentially blockbuster drug and related agreements.
Representing a subsidiary of major U.S. health care provider in the negotiation of highly complex long-term agreements for cross-border outsourcing of operations.
Advising a Netherlands branch of a major European pharmaceutical concern in negotiation to acquire rights to key technology from an about-to-go-public U.S. corporation.
Representing the same Netherlands branch of a major European pharmaceutical concern in negotiations in India with a prospective supplier.
Advising the board of directors of a major U.S. public company regarding governance and executive compensation matters amid changes of its Chief Executive Officer and Chief Financial Officer.
Representing a major U.S. distributor of silicon in negotiations for a long-term supply agreement with an Iceland-based entity.
Counseling a U.S. individual in connection with his agreement to lead a publicly held Netherlands-based water distribution corporation.
Representing a Hong Kong-based German national in ongoing employment negotiations with a Kuwait-based multinational logistics firm.